11,841 Shares in Humana Inc. (NYSE:HUM) Bought by Dupree Financial Group LLC

Dupree Financial Group LLC purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 11,841 shares of the insurance provider's stock, valued at approximately $3,004,000. Humana comprises 1.4% of Dupree Financial Group LLC's investment portfolio, making the stock its 25th biggest holding.

A number of other institutional investors have also made changes to their positions in HUM. International Assets Investment Management LLC increased its position in Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock worth $2,340,660,000 after buying an additional 738,701 shares during the period. FMR LLC increased its holdings in shares of Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the period. Thrivent Financial for Lutherans raised its holdings in Humana by 55.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider's stock valued at $190,145,000 after acquiring an additional 214,535 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock worth $793,830,000 after acquiring an additional 187,903 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new stake in shares of Humana during the 3rd quarter worth approximately $50,102,000. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

Shares of HUM traded down $5.02 during mid-day trading on Wednesday, hitting $290.52. 1,102,501 shares of the company traded hands, compared to its average volume of 1,506,460. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $34.98 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 2.21 and a beta of 0.56. The business has a 50-day moving average of $275.13 and a 200 day moving average of $299.72. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Wells Fargo & Company reduced their target price on Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. Piper Sandler lifted their target price on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Royal Bank of Canada dropped their price target on shares of Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. TD Cowen lifted their price objective on Humana from $261.00 to $268.00 and gave the company a "hold" rating in a report on Monday, November 4th. Finally, Stephens reissued an "equal weight" rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $297.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.29% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.